Picodya Technologies Ltd.
Prof David Margel MD, PhD, MBA is a distinguished Professor of Surgery at the University of Tel-Aviv School of Medicine, currently serving as a Medical Doctor at Assuta Hospital Ramat HaHayal and at Rabin Medical Center & Tel-Aviv University & Raphael Hospital. David Margel founded and leads the prostate cancer focal treatment program at Rabin Medical Center. With extensive training and experience, David Margel completed an Executive MBA in Health Innovation from Reichman University and earned a PhD in Clinical Epidemiology from the University of Toronto, where a Uro-oncology fellowship was also completed. David Margel holds an MD from The Hebrew University of Jerusalem, underscoring a solid educational foundation in medicine and surgical practice.
This person is not in the org chart
This person is not in any offices
Picodya Technologies Ltd.
Picodya offers technology that empowers wider diagnostics access around the globe. The company's in vitro diagnostics (IVD) platform can be widely used in ICUs, hospital departments, field hospitals, clinics, and home healthcare settings. The B-MatrixTM technology from Picodya eliminates the need for centralized labs, specialized people,challenging logistics, and protracted wait times by bringing quick IV diagnostics to any site.